ULTRASOUND ECHOGENICITY CAN RISK STRATIFY LESIONS ON MP-MRI FOR CLINICALLY SIGNIFICANT PROSTATE CANCER

被引：0
|
作者：
Wegner, Garret [1 ]
Khan, Amir [1 ]
Panagos, Michael [1 ]
Wang, Shu [1 ]
Van Besien, Alexa J. [1 ]
Naslund, Michael James [1 ]
Siddiqui, Mohummad Minhaj [1 ]
机构：
[1] Univ Maryland, Sch Med, College Pk, MD 20742 USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷
关键词：
D O I：
10.1016/j.urolonc.2024.01.215
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
178
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [1] ECHOGENICITY ENHANCES RISK ASSESSMENT OF LESIONS ON MP-MRI FOR CLINICALLY SIGNIFICANT PROSTATE CANCER
    Wegner, Garret
    Khan, Amir
    Panagos, Michael
    Wang, Shu
    Van Besien, Alexa J.
    Naslund, Michael
    Siddiqui, Mohummad Minhaj
    JOURNAL OF UROLOGY, 2024, 211 (05): : E302 - E302
  • [2] mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer - a retrospective review of 92 biopsied PIRADS 3 Lesions
    Liddell, H.
    Jyoti, R.
    Haxhimolla, H. Z.
    BJU INTERNATIONAL, 2015, 115 : 95 - 96
  • [3] PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer
    Frisbie, James W.
    Van Besien, Alexa J.
    Lee, Adrianna
    Xu, Linhan
    Wang, Shu
    Choksi, Ankur
    Afzal, M. Adil
    Naslund, Michael J.
    Lane, Barton
    Wong, Jade
    Wnorowski, Amelia
    Siddiqui, Mohummad Minhaj
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (02) : 347 - 352
  • [4] PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer
    James W. Frisbie
    Alexa J. Van Besien
    Adrianna Lee
    Linhan Xu
    Shu Wang
    Ankur Choksi
    M. Adil Afzal
    Michael J. Naslund
    Barton Lane
    Jade Wong
    Amelia Wnorowski
    Mohummad Minhaj Siddiqui
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 347 - 352
  • [5] WHERE IS MP-MRI MORE ACCURATE IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER? AN ANALYSIS BASED ON ANATOMICAL PROSTATE AREAS
    Oglio, Paolo Dell'
    Stabile, Armando
    Boeri, Luca
    De Cobelli, Francesco
    Scuderi, Simone
    Brembilla, Giorgio
    Fossati, Nicola
    Gandaglia, Giorgio
    Zaffuto, Emanuele
    Esposito, Antonio
    Soligo, Matteo
    Capitanio, Umberto
    Barletta, Francesco
    Karnes, R. Jeffrey
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2019, 201 (04): : E518 - E518
  • [6] Size correlation of prostate cancer lesions on multiparametric MRI (mp-MRI) and wholemount pathology
    Aslim, E. J.
    Tay, K. J.
    Law, T.
    Law, Y. M.
    Ngo, T.
    Ho, H.
    Cheng, C.
    Lee, L. S.
    Yuen, J.
    Chen, K.
    Lau, W.
    BJU INTERNATIONAL, 2018, 122 : 20 - 20
  • [7] PIRADS 3 LESIONS CHARACTERISED BY MP-MRI OF THE PROSTATE CORRESPOND WITH AN INTERMEDIATE TO HIGH RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER ON WHOLE SPECIMEN HISTOPATHOLOGY-A RETROSPECTIVE REVIEW OF 42 CASES
    Scott, Susan E.
    Gianduzzo, Troy
    Coughlin, Geoff
    Kua, Boon
    Parkinson, Rob
    Samaratunga, Hemamali
    Yaxley, John
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 59 - 59
  • [8] The Role of mp-MRI in the Detection of Prostate Cancer
    Abd Alazeez, M.
    Ahmed, H.
    Moore, C.
    Kirkham, A.
    Freeman, A.
    Emberton, M.
    CLINICAL ONCOLOGY, 2012, 24 (02) : 154 - 154
  • [9] Can transrectal prostate ultrasound compete with multiparametric MRI in the detection of clinically significant prostate cancer?
    Grey, Alistair D. R.
    Connor, Martin J.
    Tam, Joseph
    Loch, Tillmann
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (03) : 1492 - 1500
  • [10] Evaluating the risk of clinically significant prostate cancer in lesions detected on multiparametric MRI of the prostate.
    Molokwu, Chidi N.
    Gkikas, Christos
    Lee, Nicola
    Lesniak-Buzon, Joanna
    Ali, Faisal
    Bardgett, Harry
    CANCER PREVENTION RESEARCH, 2023, 16 (01)
12345